106 related articles for article (PubMed ID: 2825687)
1. Different sensitivities of Ca2+, calmodulin-dependent cyclic nucleotide phosphodiesterases from rabbit aorta and brain to dihydropyridine calcium channel blockers.
Matsushima S; Tanaka T; Saitoh M; Watanabe M; Hidaka H
Biochem Biophys Res Commun; 1987 Nov; 148(3):1468-74. PubMed ID: 2825687
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
Sharma RK; Wang JH; Wu Z
J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
[TBL] [Abstract][Full Text] [Related]
4. Interaction of the dihydropyridine calcium antagonist, CD-349, with calmodulin.
Tanaka M; Muramatsu M; Aihara H; Otomo S
Biochem Pharmacol; 1990 Sep; 40(5):991-6. PubMed ID: 2167684
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase.
Norman JA; Ansell J; Phillips MA
Eur J Pharmacol; 1983 Sep; 93(1-2):107-12. PubMed ID: 6313398
[TBL] [Abstract][Full Text] [Related]
6. KS-505a, an isoform-selective inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Ichimura M; Eiki R; Osawa K; Nakanishi S; Kase H
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):311-6. PubMed ID: 8645223
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
8. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
Ahn HS; Crim W; Romano M; Sybertz E; Pitts B
Biochem Pharmacol; 1989 Oct; 38(19):3331-9. PubMed ID: 2554921
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by new anthraquinone compounds, K-259-2 and KS-619-1, of calmodulin-dependent cyclic nucleotide phosphodiesterase.
Matsuda Y; Nakanishi S; Nagasawa K; Kase H
Biochem Pharmacol; 1990 Mar; 39(5):841-9. PubMed ID: 2155616
[TBL] [Abstract][Full Text] [Related]
12. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
Hidaka H; Asano T; Shimamoto T
Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta.
Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
Am J Hypertens; 1988 Jul; 1(3 Pt 1):262-8. PubMed ID: 2455529
[TBL] [Abstract][Full Text] [Related]
14. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.
Hagiwara M; Endo T; Hidaka H
Biochem Pharmacol; 1984 Feb; 33(3):453-7. PubMed ID: 6322804
[TBL] [Abstract][Full Text] [Related]
15. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective inhibition of calmodulin-dependent cAMP phosphodiesterase from bovine heart by (+)- and (-)-nimodipine.
Schächtele C; Wagner B; Marmé D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):340-3. PubMed ID: 3035384
[TBL] [Abstract][Full Text] [Related]
17. Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells.
Nègre-Salvayre A; Fitoussi G; Troly M; Salvayre R
Biochem Pharmacol; 1992 Dec; 44(12):2379-86. PubMed ID: 1472103
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bovine brain cyclic nucleotide phosphodiesterase by a proteinaceous factor from Escherichia coli.
Iwasa Y
Horm Metab Res; 1982 May; 14(5):265-7. PubMed ID: 6284629
[TBL] [Abstract][Full Text] [Related]
19. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
20. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
